We are live on ! Find out more
IDXX icon

Idexx Laboratories

352 hedge funds and large institutions have $6.87B invested in Idexx Laboratories in 2014 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 93 increasing their positions, 131 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 28

120% more funds holding in top 10

Funds holding in top 10: 511 (+6)

48% more call options, than puts

Call options by funds: $3.84M | Put options by funds: $2.6M

22% more capital invested

Capital invested by funds: $5.62B → $6.87B (+$1.24B)

10% more funds holding

Funds holding: 319352 (+33)

29% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 131

Holders
352
Holders Change
+33
Holders Change %
+10.34%
% of All Funds
9.35%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.29%
New
65
Increased
93
Reduced
131
Closed
28
Calls
$3.84M
Puts
$2.6M
Net Calls
+$1.25M
Net Calls Change
+$3.4M

IDXX Hedge Fund Activity: Q4 2014 in Review

352 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2014, worth a combined $6.87B — up 22% from $5.62B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new IDXX positions and 28 closed out — a net gain of 37 holders — while 93 added to existing stakes and 131 trimmed.

The largest buyer was Wells Fargo, adding an estimated $101M. The largest seller was T. Rowe Price Associates, cutting an estimated $207M.

  • 352 institutional investors held Idexx Laboratories (IDXX) as of Q4 2014, up from 319 in Q3 2014.
  • Funds reported $6.87B of Idexx Laboratories stock for Q4 2014, up 22% quarter-over-quarter.
  • 65 funds opened new Idexx Laboratories positions in Q4 2014 and 28 closed out, a net change of +37 holders.
  • The largest Idexx Laboratories buyer in Q4 2014 was Wells Fargo, an estimated $101M added.
  • The largest Idexx Laboratories seller in Q4 2014 was T. Rowe Price Associates, an estimated $207M sold.

Based on aggregated 13F filings for Q4 2014.